Allocryptopine B

CAS No. 485-91-6

Allocryptopine B( Allocryptopine )

Catalog No. M19327 CAS No. 485-91-6

Allocryptopine induces muscle contraction and relaxation in urinary bladder and ileum, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 51 In Stock
2MG 28 In Stock
5MG 44 In Stock
10MG 62 In Stock
25MG 102 In Stock
50MG 149 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Allocryptopine B
  • Note
    Research use only, not for human use.
  • Brief Description
    Allocryptopine induces muscle contraction and relaxation in urinary bladder and ileum, respectively.
  • Description
    Allocryptopine induces muscle contraction and relaxation in urinary bladder and ileum, respectively.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Allocryptopine
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    Sodium Channel
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    485-91-6
  • Formula Weight
    369.4
  • Molecular Formula
    C21H23NO5
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (135.35 mM)
  • SMILES
    COC1=C(OC)C2=C(CC(=O)C3=CC4=C(OCO4)C=C3CCN(C)C2)C=C1
  • Chemical Name
    5,7,8,15-Tetrahydro-3,4-dimethoxy-6-methyl(1,3)benzodioxolo(5,6-e)(2)benzazecin-14(6H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Huang Y, et al. Rapid Commun Mass Spectrom. 2016 Jul 15;30(13):1549-59.
molnova catalog
related products
  • Butacaine

    Butacaine is a local anesthetic.

  • ProTx II

    Selective NaV1.7 channel blocker. Shifts activation gating positively and decreases current magnitude. Displays 100-fold selectivity over other sodium channel subtypes.

  • LTGO-33

    LTGO-33 is a species-specific inhibitor of the voltage-gated sodium channel NaV1.8, inhibiting NaV1.8, NaV1.1-NaV1.7, and NaV1.9.